Woodline Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.24M | Hold |
500,416
| – | – | 0.02% | 594 |
|
|
2025
Q1 | $4.02M | Sell |
500,416
-349,061
| -41% | -$2.81M | 0.03% | 556 |
|
|
2024
Q4 | $7.63M | Buy |
849,477
+348,983
| +70% | +$3.13M | 0.05% | 405 |
|
|
2024
Q3 | $3.67M | Sell |
500,494
-113,572
| -18% | -$832K | 0.03% | 425 |
|
|
2024
Q2 | $3.51M | Buy |
614,066
+113,511
| +23% | +$648K | 0.03% | 371 |
|
|
2024
Q1 | $2.51M | Sell |
500,555
-144,639
| -22% | -$725K | 0.02% | 412 |
|
|
2023
Q4 | $5.8M | Buy |
645,194
+145,194
| +29% | +$1.31M | 0.06% | 297 |
|
|
2023
Q3 | $3.89M | Hold |
500,000
| – | – | 0.05% | 339 |
|
|
2023
Q2 | $4.84M | Sell |
500,000
-453,462
| -48% | -$4.39M | 0.06% | 297 |
|
|
2023
Q1 | $10.4M | Sell |
953,462
-271,991
| -22% | -$2.98M | 0.14% | 192 |
|
|
2022
Q4 | $5.29M | Buy |
+1,225,453
| New | +$5.29M | 0.07% | 304 |
|
|
2022
Q3 | – | Sell |
-169,209
| Closed | -$1.7M | – | 751 |
|
|
2022
Q2 | $1.7M | Buy |
+169,209
| New | +$1.7M | 0.03% | 454 |
|